How do employees rate Novavax?

Employees rate Novavax 3.1 out of 5 stars based on 277 anonymous reviews on Glassdoor.

How can I get a job at Novavax?

To get a job at Novavax, browse currently open positions and apply for a job near you. Once you get a positive response, make sure to find out about the interview process at Novavax and prepare for tough questions.

Do people recommend working at Novavax?

Overall, 36% of employees would recommend working at Novavax to a friend. This is based on 277 anonymously submitted reviews on Glassdoor.

How do job seekers rate their interview experience at Novavax?

58% of job seekers rate their interview experience at Novavax as positive. Candidates give an average difficulty score of 2.8 out of 5 (where 5 is the highest level of difficulty) for their job interview at Novavax.

How do employees rate the business outlook for Novavax?

25% of employees think that Novavax has a positive business outlook . This is based on anonymous employee reviews submitted on Glassdoor.

Skip to content Skip to footer

Notifications

Novavax

Novavax Snapshot

3.1

based on 278 ratings

36% would recommend to a friend

John C. Jacobs

45% approve of CEO

2 OfficesLocations

Mission We never rest in our quest to protect the health of people everywhere.

Description Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company's proprietary recombinant technology platform harnesses the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs. NVX-CoV2373, the company's COVID-19 vaccine, received Conditional Marketing Authorization from the European Commission, Emergency Use Listing from the World Health Organization, Emergency Use Authorization in Indonesia and the Philippines, and has been submitted for regulatory authorization in multiple markets globally. NanoFlu™, the company's quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults. Novavax is currently evaluating a COVID-NanoFlu combination vaccine in a Phase 1/2 clinical trial, which combines the company's NVX-CoV2373 and NanoFlu vaccine candidates. These vaccine candidates incorporate Novavax' proprietary saponin-based Matrix-M™ adjuvant to enhance the immune response and stimulate high levels of neutralizing antibodies.

For more information, visit www.novavax.com and connect with us on Twitter, LinkedIn, Instagram and Facebook.

View our pipeline at https://www.novavax.com/our-pipeline

Life at Novavax

Photos

Novavax photo of: Party in the Parking Lot

Novavax awards and accolades

2021 Industry Awards, Maryland Tech Council, 2021
BioBuzz Maryland Employer of The Year, BioBuzz Maryland, 2021

Employee reviews at Novavax

Novavax has an employee rating of 3.1 out of 5 stars, based on 278 company reviews on Glassdoor which indicates that most employees have a good working experience there. The Novavax employee rating is in line with the average (within 1 standard deviation) for employers within the Pharmaceutical and biotechnology industry (3.5 stars).

Ratings by category

3.9

Compensation and benefits

3.6

Diversity and inclusion

3.3

Work/Life balance

3.0

Culture and values

2.9

Career opportunities

2.6

Senior management

Employee reviews

Business analystFormer employee

3.0

Remote work available, but poor work-life balance

Novavax FAQs

Related searches: Novavax jobs | Novavax salaries | Novavax benefits | Novavax interviews

Companies About Novavax

Novavax

Novavax Snapshot